Patient Advisory Board

Which technologies are easy to use, and which are not? What are ‘functions’ that are meaningful to monitor remotely? And how can a clinical trial be ‘participant-friendly’? These and many other questions are being addressed through consultation sessions with the standing RADAR-AD Patient Advisory Board (PAB).

The PAB is an international group of patients and support groups that accompanies the project from beginning to end, advising both on conceptual questions as well as on practical issues such as trial setup. In addition, specific topics will be addressed by focus groups organized in different countries, for example exploring cultural differences in acceptance of certain technologies.

Alzheimer Europe is leading activities of the PAB, and King’s College London is leading focus group activities. Lygature is supporting the activities with program management capacity.